PE23396A1 - Benzotiofeno de glucopiranosido - Google Patents

Benzotiofeno de glucopiranosido

Info

Publication number
PE23396A1
PE23396A1 PE1995268768A PE26876895A PE23396A1 PE 23396 A1 PE23396 A1 PE 23396A1 PE 1995268768 A PE1995268768 A PE 1995268768A PE 26876895 A PE26876895 A PE 26876895A PE 23396 A1 PE23396 A1 PE 23396A1
Authority
PE
Peru
Prior art keywords
benzotiofen
glucopyranoside
chem
solvate
processes
Prior art date
Application number
PE1995268768A
Other languages
English (en)
Inventor
Charles Alan Frolik
Jeffrey Alan Dodge
Gilbert Stanley Staten
Terry Donald Lindstrom
Iii Charles Willis Lugar
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PE23396A1 publication Critical patent/PE23396A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Networks Using Active Elements (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA (Ia) Y (Ib) O UNA DE SUS SALES O SOLVATOS FARMACEUTICAMENTE ACEPTABLES, DE PREFERENCIA CLORHIDRATO, QUE SE PUEDE HALLAR EN FORMA PURA O CON EXCIPIENTES PARA LA PREPARACION DE FORMAS FARMACEUTICAS Y A UN PROCEDIMIENTO PARA LA PREPARACION DE UN MATERIAL DE PARTIDA PARA LA SINTESIS DE DICHAS SALES DE APLICACION FARMACEUTICA, TODO EN MEDIO ANHIDRO. LAS SALES DE ADICION ACIDA SE FORMAN POR REACCION DEL COMPUESTO ANTES MENCIONADO CON UNA CANTIDAD EQUIMOLAR O EN EXCESO DE ACIDO, PROCESO QUE LLEVA A LA PRECIPITACION DE LA SAL EN UN LAPSO DE UNA HORA A 10 DIAS, AISLANDOSE POR FILTRACION, USANDOSE PARA LA FORMACION DE SALES, LAS BASES TALES COMO NH4OH, NAOH, CO3K2 ENTRE OTRAS. LAS SALES FARMACEUTICAMENTE ACEPTABLES TIENEN AUMENTADA LAS CARACTERISTICAS DE SOLUBILIDAD Y SUS FORMAS DE PRESENTACION SON LA ORAL, I.M., I.V. LOS COMPUESTOS OBTENIDOS SON UTILES PARA LA DISMINUCION DE LOS NIVELES DE COLESTEROL EN SUERO Y LA INHIBICION DE LA RESORCION OSEA
PE1995268768A 1994-05-20 1995-05-16 Benzotiofeno de glucopiranosido PE23396A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24665594A 1994-05-20 1994-05-20

Publications (1)

Publication Number Publication Date
PE23396A1 true PE23396A1 (es) 1996-06-15

Family

ID=22931623

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1995268768A PE23396A1 (es) 1994-05-20 1995-05-16 Benzotiofeno de glucopiranosido

Country Status (27)

Country Link
US (2) US5567820A (es)
EP (1) EP0683170B1 (es)
JP (1) JPH07316180A (es)
KR (1) KR950032183A (es)
CN (1) CN1039013C (es)
AT (1) ATE184880T1 (es)
AU (1) AU683734B2 (es)
BR (1) BR9502079A (es)
CA (1) CA2149501A1 (es)
CO (1) CO4650137A1 (es)
CZ (1) CZ126295A3 (es)
DE (1) DE69512310T2 (es)
DK (1) DK0683170T3 (es)
ES (1) ES2136799T3 (es)
FI (1) FI952420A (es)
GR (1) GR3032142T3 (es)
HU (1) HU219335B (es)
IL (1) IL113780A (es)
NO (1) NO304694B1 (es)
NZ (1) NZ272131A (es)
PE (1) PE23396A1 (es)
PL (1) PL308635A1 (es)
RU (1) RU95107655A (es)
SI (1) SI0683170T1 (es)
TW (1) TW323285B (es)
YU (1) YU31995A (es)
ZA (1) ZA953975B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0724879A2 (en) * 1995-02-06 1996-08-07 Eli Lilly And Company 2-Phenyl-3-azoylbenzothiopenes for inhibiting effects of IL-6
US20040167080A1 (en) * 1995-03-15 2004-08-26 Dodge Jeffrey A. Glucopyranoside benzothiophenes
ES2341399T3 (es) 1996-03-26 2010-06-18 Eli Lilly And Company Benziotofenos, formulaciones que contienen los mismos y procedimientos.
US6458811B1 (en) 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
ES2246234T3 (es) 1999-05-04 2006-02-16 Strakan International Limited Glicosidos de androgenos y actividad androgenica de los mismos.
JP2003509435A (ja) * 1999-09-13 2003-03-11 ワイス 2−(4−ヒドロキシフェニル)−1−[4−(2−アミン−1−イルエトキシ)ベンジル]−1h−インドール−5−オールのグルコピラノシド複合体
US6380166B1 (en) 1999-09-13 2002-04-30 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
WO2001027129A1 (en) * 1999-10-08 2001-04-19 Strakan Limited Glycosides and orthoester glycosides of raloxifene and analogues and the use thereof
AU7674000A (en) * 1999-10-08 2001-04-23 Strakan Group Plc Tamoxifen and tamoxifen analogue glycosides and uses thereof
WO2011029088A2 (en) * 2009-09-07 2011-03-10 Dr. Reddy's Laboratories Ltd. Preparation of raloxifene and its salts

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss

Also Published As

Publication number Publication date
KR950032183A (ko) 1995-12-20
ES2136799T3 (es) 1999-12-01
EP0683170A1 (en) 1995-11-22
CZ126295A3 (en) 1995-12-13
RU95107655A (ru) 1997-02-10
DE69512310D1 (de) 1999-10-28
CN1116626A (zh) 1996-02-14
NZ272131A (en) 1996-11-26
CO4650137A1 (es) 1998-09-03
JPH07316180A (ja) 1995-12-05
HU9501466D0 (en) 1995-06-28
IL113780A (en) 1999-06-20
FI952420A (fi) 1995-11-21
SI0683170T1 (en) 2000-02-29
PL308635A1 (en) 1995-11-27
CN1039013C (zh) 1998-07-08
HUT73788A (en) 1996-09-30
ZA953975B (en) 1996-11-18
US6723739B1 (en) 2004-04-20
DE69512310T2 (de) 2000-02-03
CA2149501A1 (en) 1995-11-21
AU683734B2 (en) 1997-11-20
HU219335B (en) 2001-03-28
NO951954D0 (no) 1995-05-18
BR9502079A (pt) 1996-03-05
ATE184880T1 (de) 1999-10-15
YU31995A (sh) 1998-12-23
GR3032142T3 (en) 2000-04-27
AU2012195A (en) 1995-11-30
IL113780A0 (en) 1995-08-31
DK0683170T3 (da) 1999-12-20
US5567820A (en) 1996-10-22
FI952420A0 (fi) 1995-05-18
NO951954L (no) 1995-11-21
TW323285B (es) 1997-12-21
NO304694B1 (no) 1999-02-01
EP0683170B1 (en) 1999-09-22

Similar Documents

Publication Publication Date Title
DK0582788T3 (da) 7-(Substituerede)-9-[(substitueret glycyl)-amido]-demethyl-6-deoxytetracycliner
SG77195A1 (en) Fungicidal 2-methoxybenzophenones
PT705833E (pt) Derivado de dc-89
ES2088537T3 (es) Derivados de piranil cianoguanidina.
NO20014925D0 (no) Farmasöytiske forbindelser
ES2136887T3 (es) Derivados antifungicos de sordaridina.
PL326024A1 (en) Novel derivatives of cyclodepsipeptidic substance pf1022
ES2136799T3 (es) Benzotiofenos de glucopiranosido.
ES2196174T3 (es) `derivados de sesquiterpeno de actividad antiviral.
RU93051079A (ru) Фармацевтические соединения, способ получения, фармацевтическая композиция
ATE197953T1 (de) Pyrrolo(4,3,2-de)chinolin-derivat
ATE187331T1 (de) Benzopyranderivate
SE9602418D0 (sv) Process for the preparation of organic salts of N'N-diacetylcystine
SE9602476D0 (sv) Process for the preparation of organic salts of N'N -diacetylcystine

Legal Events

Date Code Title Description
FX Voluntary withdrawal